Status:
UNKNOWN
Effect of the Use of Symbiotics in Patients With Colon Cancer
Lead Sponsor:
Federal University of Minas Gerais
Collaborating Sponsors:
Simone de Vasconcelos Generoso
Luísa Martins Trindade
Conditions:
Symbiotic
Cancer Colorectal
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Due to the high incidence, cancer and the concomitant presence of malnutrition are currently a worldwide public health problem. The loss of weight and body tissues is a common condition in cancer pati...
Detailed Description
Most cancer patients have a compromised nutritional status, 80% are malnourished at the time of the initial diagnosis. It is known that in patients with airway and digestive cancer the risk of malnutr...
Eligibility Criteria
Inclusion
- Patients over 18 years of age, diagnosed with colorectal and head and neck cancer who will undergo a tumor resection operation
Exclusion
- Individuals who have inflammatory bowel diseases will be excluded; have previously undergone operations on the gastrointestinal tract; have used antibiotics, prebiotics, probiotics or symbiotics in the last 15 days and are on an enteral fiber diet.
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04874883
Start Date
December 1 2019
End Date
December 1 2022
Last Update
May 6 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Escola de Enfermagem - UFMG
Belo Horizonte, Minas Gerais, Brazil, 30130-100
2
Ambulatório de Transplantes Hepáticos
Belo Horizonte, Minas Gerais, Brazil